Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-06-28

FDA Approved: HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE — Supplemental Application (Novel Laboratories, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Hydrocodone bitartrate and homatropine methylbromide from Novel Laboratories, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hydrocodone Bitartrate and Homatropine Methylbromide (Hydrocodone Bitartrate and Homatropine Methylbromide)

Snippet

SUPPL AP for HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE (HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE)